The cerebellum in Parkinson's disease

Brain

Volumn 136, Issue 3, 2013, Pages 696-709

  Wu, Tao ^a   Hallett, Mark ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

cerebellum; compensation; Parkinson's disease; pathological changes

Indexed keywords

LEVODOPA;

AKINESIA; BASAL GANGLION; BRAIN DEPTH STIMULATION; BRAIN REGION; CEREBELLUM; COGNITIVE DEFECT; DYSKINESIA; HUMAN; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPATHOLOGY; ORBITAL CORTEX; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RIGIDITY; SENSORY DYSFUNCTION; SUBTHALAMIC NUCLEUS; TRANSCRANIAL MAGNETIC STIMULATION; TREMOR;

EID: 84874861183     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws360     Document Type: Review

References (170)

1. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Risk of dementia in Parkinson's disease. A community-based, prospective study. Neurology 2001; 56: 730-6.
2. Adler CH. Nonmotor complications in Parkinson's disease. Mov Disord 2005; 20 (Suppl 11): S23-9.
3. Aita JF. Why patients with Parkinson's disease fall. JAMA 1982; 247: 515-16.
4. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-81.
5. Anderson VC, Burchiel KJ, Hogarth P, Farve J, Hammerstad JP. Pallidal vs. subthalamic nucleus deep brain stimulation in Parkinson's disease. Arch Neurol 2005; 62: 554-60.
6. Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C, et al. Network modulation in the treatment of Parkinson's disease. Brain 2006; 129: 2667-78.
7. Ballanger B, Baraduc P, Broussolle E, Le Bars D, Desmurget M, Thobois S. Motor urgency is mediated by the contralateral cerebellum in Parkinson's disease. J Neurol Neurosurg Psychiatry 2008; 79: 1110-6.
8. Ballanger B, Lozano AM, Moro E, van Eimeren T, Hamani C, Chen R, et al. Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [15O] HH2OO PET study. Hum Brain Mapp 2009; 30: 3901-9.
9. Bé dard P, Sanes JN. On a basal ganglia role in learning and rehearsing visual-motor associations. Neuroimage 2009; 47: 1701-10.
10. Beitz AJ, Larson AA, Monaghan P, Altschuler RA, Mullett MM, Madl JE. Immunohistochemical localization of glutamate, glutaminase and aspartate aminotransferase in neurons of the pontine nuclei of the rat. Neuroscience 1986; 17: 741-53.
11. Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, HommelM, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991; 337: 403-6.
12. Benninger DH, Thees S, Kollias SS, Bassetti CL, Waldvogel D. Morphological differences in Parkinson's disease with and without rest tremor. J Neurol 2009; 256: 256-63.
13. Bezard E, Brotchie JM, Gross CE. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 2001; 2: 577-88.
14. Borghammer P, Østergaard K, Cumming P, Gjedde A, Rodell A, Hall N, et al. A deformation-based morphometry study of patients with early-stage Parkinson's disease. Eur J Neurol 2010; 17: 314-20.
15. Bostan AC, Dum RP, Strick PL. The basal ganglia communicate with the cerebellum. Proc Natl Acad Sci USA 2010; 107: 8452-6.
16. Braak H, Del TK, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
17. Brusa L, Ceravolo R, Kiferle L, Monteleone F, Iani C, Schillaci O, et al. Metabolic changes induced by theta burst stimulation of the cerebellum in dyskinetic Parkinson's disease patients. Parkinsonism Relat Disord 2012; 18: 59-62.
18. Buhmann C, Glauche V, Sturenburg HJ, Oechsner M, Weiller C, Buchel C. Pharmacologically modulated fMRI -cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain 2003; 126: 451-61.
19. Camicioli R, Gee M, Bouchard TP, Fisher NJ, Hanstock CC, Emery DJ, Martin WR. Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism. Parkinsonism Relat Disord 2009; 15: 187-95.
20. Cao H, Xu X, Zhao Y, Long D, Zhang M. Altered brain activation and connectivity in early Parkinson disease tactile perception. AJNR Am J Neuroradiol 2011; 32: 1969-74.
21. Catalan MJ, Ishii K, Honda M, Samii A, Hallett M. A PET study of sequential finger movements of varying length in patients with Parkinson's disease. Brain 1999; 122: 483-95.
22. Cerasa A, Hagberg GE, Peppe A, Bianciardi M, Gioia MC, Costa A, et al. Functional changes in the activity of cerebellum and frontostriatal regions during externally and internally timed movement in Parkinson's disease. Brain Res Bull 2006; 71: 259-699
23. Chiba-Falek O, Lopez GJ, Nussbaum RL. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov Disord 2006; 21: 1703-8.
24. Chollet F, DiPiero V, Wise RJ, Brooks DJ, Dolan RJ, Frackowiak RS. The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography. Ann Neurol 1991; 29: 63-71.
25. Cilia R, Marotta G, Landi A, Isaias IU, Mariani CB, Vergani F, et al. Clinical and cerebral activity changes induced by subthalamic nucleus stimulation in advanced Parkinson's disease: a prospective case-control study. Clin Neurol Neurosurg 2009; 111: 140-6.
26. Connelly T, Farmer JM, Lynch DR, Doty RL. Olfactory dysfunction in degenerative ataxias. J Neurol Neurosurg Psychiatry 2003; 74: 1435-7.
27. Deiber MP, Passingham RE, Colebatch JG, Friston KJ, Nixon PD, Frackowiak RS. Cortical areas and the selection of movement: a study with positron emission tomography. Exp Brain Res 1991; 84: 393-402.
28. Deiber MP, Pollak P, Passingham R, Landais P, Gervason C, Cinotti L, et al. Thalamic stimulation and suppression of parkinsonian tremor. Evidence of a cerebellar deactivation using positron emission tomography. Brain 1993; 116: 267-279.
29. Deuschl G, Raethjen J, Baron R, Lindemann M, Wilms H, Krack P. The pathophysiology of parkinsonian tremor: a review. J Neurol 2000; 247 (Suppl 5): V33-48.
30. Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 2008; 283: 9089-100.
31. Dreher JC, Grafman J. The roles of the cerebellum and basal ganglia in timing and error prediction. Eur J Neurosci 2002; 16: 1609-19.
32. Eckert T, Tang C, Eidelberg D. Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol 2007; 6: 926-32.
33. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci 2009; 32: 548-57.
34. Fahn S. The spectrum of levodopa-induced dyskinesias. Ann Neurol 2000; 47: S2-9.
35. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantianigra regional selectivity. Brain 1991; 114: 2283-01.
36. Ferdon S, Murphy C. The cerebellum and olfaction in the aging brain: a functional magnetic resonance imaging study. Neuroimage 2003; 20: 12-21.
37. Forno S. Pathology of Parkinson's disease. In: Marsden CD, Fahn S, editors. Movement disorders, neurology. 2nd edn. Cornwall: Butterworth Scientific; 1981. p. 21-40.
38. Fuchs J, Tichopad A, Golub Y, Munz M, Schweitzer KJ, Wolf B, et al. Genetic variability in the SNCA gene influences-synuclein levels in the blood and brain. FASEB J 2008; 22: 1327-34.
39. Fukuda M, Barnes A, Simon ES, Holmes A, Dhawan V, Giladi N, et al. Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics. Neuroimage 2004; 21: 608-15.
40. Geday J, Østergaard K, Johnsen E, Gjedde A. STN-stimulation in Parkinson's disease restores striatal inhibition of thalamocortical projection. Hum Brain Mapp 2009; 30: 112-21.
41. Ghez C, Fahn S. The cerebellum. In: Kandel ER, Schwartz JH, editors. Principles of neural science. 2nd edn. New York: Elsevier; 1985. p. 502-22.
42. Gilman S, Koeppe RA, Nan B, Wang CN, Wang X, Junck L, et al. Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology 2010; 74: 1416-23.
43. Giompres P, Delis F. Dopamine transporters in the cerebellum of mutant mice. Cerebellum 2005; 4: 105-11.
44. Goerendt IK, Lawrence AD, David J, Brooks DJ. Reward processing in health and Parkinson's disease: neural organization and reorganization. Cereb Cortex 2004; 14: 73-80.
45. Grafton ST, Turner RS, Desmurget M, Bakay R, Delong M, Vitek J, Crutcher M. Normalizing motor-related brain activity: Subthalamic nucleus stimulation in Parkinson disease. Neurology 2006; 66: 1192-9.
46. Gründemann J, Schlaudraff F, Haeckel O, Liss B. Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease. Nucleic Acids Res 2008; 36: e38.
47. Guehl D, Pessiglione M, Francois C, Yelnik J, Hirsch EC, Feger J, et al. Tremor-related activity of neurons in the 'motor' thalamus: changes in firing rate and pattern in the MPTP vervet model of parkinsonism. Eur J Neurosci 2003; 17: 2388-400.
48. Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, Silburn PA, et al. Prevalence of smell loss in Parkinson's disease-a multicenter study. Parkinsonism Relat Disord 2009; 15: 490-4.
49. Hallett M, Khoshbin S. A physiological mechanism of bradykinesia. Brain 1980; 103: 301-14.
50. Hallett M, Cohen LG, Bierner SM. Studies of sensory and motor cortex physiology: with observations on akinesia in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1991; 43 (Suppl.): 76-85.
51. Hanakawa T, Katsumi Y, Fukuyama H, Honda M, Hayashi T, Kimura J, et al. Mechanisms underlying gait disturbance in Parkinson's disease: a single photon emission computed tomography study. Brain 1999; 122: 1271-82.
52. Haslinger B, Erhard P, Kampfe N, Boecker H, Rummeny E, Schwaiger M, et al. Event-related Functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 2001; 124: 558-70.
53. Helmich RC, Aarts E, de Lange FP, Bloem BR, Toni I. Increased dependence of action selection on recent motor history in Parkinson's disease. J Neurosci 2009; 29: 6105-13.
54. Helmich RC, Janssen MJ, Oyen WJ, Bloem BR, Toni I. Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Ann Neurol 2011; 69: 269-81.
55. Heman P, Barcia C, Gó mez A, Ros CM, Ros-Bernal F, Yuste JE, et al. Nigral degeneration correlates with persistent activation of cerebellar Purkinje cells in MPTP-treated monkeys. Histol Histopathol 2012; 27: 89-94.
56. Hilker R, Schweitzer K, Coburger S, Ghaemi M, Weisenbach S, Jacobs AH, et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol 2005; 62378-82.
57. Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 2004; 24: 7-16.
58. Hillen ME, Sage JI. Nonmotor fluctuations in patients with Parkinson's disease. Neurology 1996; 47: 1180-3.
59. Hornykiewicz O. The discovery of dopamine deficiency in the parkinsonian brain. J Neural Transm 2006; 70: 9-15.
60. Hoshi E, Tremblay L, Fé ger J, Carras PL, Strick PL. The cerebellum communicates with the basal ganglia. Nat Neurosci 2005; 8: 1491-3.
61. Hu MT, Taylor-Robinson SD, Chaudhuri KR, Bell JD, Labbe C, Cunningham VJ, et al. Cortical dysfunction in non-demented Parkinson's disease patients. A combined 31P-MRS and 18FDG-PET Study. Brain 2000; 123: 340-52.
62. Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D. Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage 2007a; 34: 714-23.
63. Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, et al. Changes in network activity with the progression of Parkinson's disease. Brain 2007b; 130: 1834-46.
64. Hurley MJ, Mash DC, Jenner P. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR. Eur J Neurosci 2003; 18: 2668-72.
65. Ichinohe N, Mori F, Shoumura K. A di-synaptic projection from the lateral cerebellar nucleus to the laterodorsal part of the striatum via the central lateral nucleus of the thalamus in the rat. Brain Res 2000; 880: 191-7.
66. Ikai Y, Takada M, Shinonaga Y, Mizuno N. Dopaminergic and non-dopaminergic neurons in the ventral tegmental area of the rat project, respectively, to the cerebellar cortex and deep cerebellar nuclei. Neuroscience 1992; 51: 719-28.
67. Ikeda A, Shibasaki H, Nagamine T, Terada K, Kaji R, Fukuyama H, et al. Dissociation between contingent negative variation and Bereitschafts potential in a patient with cerebellar efferent lesion. Electroencephalogr Clin Neurophysiol 1994; 90: 359-64.
68. Ito K, Nagano-Saito A, Kato T, Arahata T, Nakamura A, Kawasumi Y, Hatano K, et al. Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[(18)]fluoro-L-dopa PET study. Brain 2002; 125: 1358-65.
69. Jahanshahi M, Jenkins H, Brown RG, Marsden CD, Passingham RE, Brooks DJ. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 1995; 118: 913-933.
70. Jahanshahi M, Jones CR, Zijlmans J, Katzenschlager R, Lee L, Quinn N, et al. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease. Brain 2010; 133: 727-45.
71. Jaillard A, Martin CD, Garambois K, Lebas JF, Hommel M. Vicarious function within the human primary motor cortex? A longitudinal fMRI stroke study. Brain 2005; 128: 1122-38.
72. Jankovic J. Progression of Parkinson disease: are we making progress in charting the course? Arch Neurol 2005; 62: 351-2.
73. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008; 79: 368-76.
74. Jenkins IH, Jahanshahi M, Jueptner M, Passingham RE, Brooks DJ. Selfinitiated versus externally triggered movements. II. The effect of movement predictability on regional cerebral blood flow. Brain 2000; 123: 1216-1228.
75. Jones EG. The thalamus. New York: Plenum; 1985.
76. Kawashima R, Okuda J, Umetsu A, Sugiura M, Inoue K, Suzuki K, et al. Human cerebellum plays an important role in memory-timed finger movement: an fMRI study. J Neurophysiol 2000; 83: 1079-87.
77. Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ. Alteration in alpha-synuclein mRNA expression in Parkinson's disease. Mov Disord 2004; 19: 162-70.
78. Kitai ST, Kita H. The Basal Ganglia II -structure and function: current concepts. In: Carpenter MB, Jayaraman A, editors. Plenum: New York; 1987. p. 357-73.
79. Koch G, Brusa L, Carrillo F, Lo Gerfo E, Torriero S, Oliveri M, et al. Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease. Neurology 2009; 73: 113-9.
80. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-34.
81. Krack P, Pollak P, Limousin P, Benazzouz A, Benabid AL. Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease. Lancet 1997; 350: 1676.
82. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003; 4: 469-80.
83. Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol 2000; 47: 493-503.
84. Lenz FA, Normand SL, Kwan HC, Andrews D, Rowland LH, Jones MW, et al. Statistical prediction of the optimal site for thalamotomy in parkinsonian tremor. Mov Disord 1995; 10: 318-28.
85. Lewis MM, Du G, Sen S, Kawaguchi A, Truong Y, Lee S, et al. Differential involvement of striato-and cerebello-thalamo-corticalpathways in tremor-and akinetic/rigid-predominant Parkinson's disease. Neuroscience 2011; 177: 230-9.
86. Lozano AM, Lang AE, Levy R, Hutchison W, Dostrovsky J. Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine. Ann Neurol 2000; 47: S141-6.
87. Lozza C, Marie RM, Baron JC. The metabolic substrates of bradykinesia and tremor in uncomplicated Parkinson's disease. Neuroimage 2002; 17: 688-99.
88. Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab 2007; 27: 597-605.
89. Mainland JD, Johnson BN, Khan R, Ivry RB, Sobel N. Olfactory impairments in patients with unilateral cerebellar lesions are selective to inputs from the contralesional nostril. J Neurosci 2005; 25: 6362-71.
90. Mallol R, Barró s-Loscertales A, Ló pez M, Belloch V, Parcet MA, Avila C. Compensatory cortical mechanisms in Parkinson's disease evidenced with fMRI during the performance of pre-learned sequential movements. Brain Res 2007; 1147: 265-71.
91. Melchitzky DS, Lewis DA. Tyrosine hydroxylase-and dopamine transporter-immunoreactivity axons in the primate cerebellum. Evidence for a lobular-and laminar-specific dopamine innervation. Neuropsychopharmacology 2000; 22: 466-72.
92. Mentis MJ, Dhawan V, Nakamura T, Ghilardi MF, Feigin A, Edwards C, et al. Enhancement of brain activation during trial-and-error sequence learning in early PD. Neurology 2003; 60: 612-9.
93. Mentis MJ, McIntosh AR, Perrine K, Dhawan V, Berlin B, Feigin A, et al. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry 2002; 159: 746-754.
94. Middleton FA, Strick PL. Basal ganglia and cerebellar loops: Motor and cognitive circuits. Brain Res Brain Res Rev 2000; 31: 236-50.
95. Middleton FA, Strick PL. Cerebellar projections to the prefrontal cortex of the primate. J Neurosci 2001; 21: 700-12.
96. Mink J. The basal ganglia: focused selection and inhibition of competingmotor programs. Prog Neurobiol 1996; 50: 381-425.
97. Moers-Hornikx VM, Vles JS, Tan SK, Cox K, Hoogland G, Steinbusch WM, et al. Cerebellar nuclei are activated by high-frequency stimulation of the subthalamic nucleus. Neurosci Lett 2011; 496: 111-5.
98. Morris M, Iansek R, Matyas T, Summers J. Abnormalities in the stride length-cadence relation in parkinsonian gait. Mov Disord 1998; 13: 61-69.
99. Moscovich M, Munhoz RP, Teive HA, Raskin S, Carvalho Mde J, Barbosa ER, Ranvaud R, Liu J, McFarland K, Ashizawa T, Lees AJ, Silveira-Moriyama L. Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry 2012; 83: 970-4.
100. Mure H, Hirano S, Tang CC, Isaias IU, Antonini A, Ma Y, et al. Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects. NeuroImage 2011; 54: 1244-53.
101. Nagano-Saito A, Kato T, Arahata Y, Washimi Y, Nakamura A, Abe Y, et al. Cognitive-and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies. Neuroimage 2004; 22: 553-61.
102. Nagaoka T, Katayama Y, Kano T, Kobayashi K, Oshima H, Fukaya C, et al. Changes in glucose metabolism in cerebral cortex and cerebellum correlate with tremor and rigidity control by subthalamic nucleus stimulation in Parkinson's disease: a positron emission tomography study. Neuromodulation 2007; 10: 206-15.
103. Neystat M, Lynch T, Przedborski S, Kholodilov N, Rzhetskaya M, Burke RE. (1999) Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease. Mov Disord 1999; 14: 417-22.
104. Ni Z, Pinto AD, Lang AE, Chen R. Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol 2010; 68: 816-24.
105. Nimura T, Ando T, Yamaguchi K, Nakajima T, Shirane R, Itoh M, et al. The role of sigma-receptors in levodopa-induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study. J Neurosurg 2004; 100: 606-10.
106. Nishio Y, Hirayama K, Takeda A, Hosokai Y, Ishioka T, Suzuki K, Itoyama Y, Takahashi S, Mori E. Corticolimbic gray matter loss in Parkinson's disease without dementia. Eur J Neurol 2010; 17: 1090-7.
107. Ohishi H, Ichikawa J, Matsuzaki R, Kyuhou S, Matsuura-Nakao K, et al. Cortical field potentials preceding self-paced forelimb movements and influences of cerebellectomy upon them in rats. Neurosci Lett 2003; 352: 5-8.
108. Palmer SJ, Eigenraam L, Hoque T, McCaig RG, Troiano A, McKeown MJ. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease. Neuroscience 2009; 158: 693-704.
109. Palmer SJ, Li J, Wang ZJ, McKeown MJ. Joint amplitude and connectivity compensatory mechanisms in Parkinson's disease. Neuroscience 2010; 166: 1110-1118.
110. Panagopoulos NT, Panagopoulos GC, Matsokis NA. Dopaminergic innervation and binding in the rat cerebellum. Neurosci Lett 1991; 130: 208-12.
111. Papavassiliou E, Rau G, Heath S, Abosch A, Barbaro NM, Larson PS, Lamborn K, Starr PA. Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome. Neurosurgery 2008; 62 (Suppl 2): 884-894.
112. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 1995; 20: 91-127.
113. Paulus W, Jellinger K. Theneuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991; 50: 743-55.
114. Payoux P, Remy P, Damier P, Miloudi M, Loubinoux I, Pidoux B, et al. Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease. Arch Neurol 2004; 61: 1307-13.
115. Payoux P, Remy P, Miloudi M, Houeto JL, Stadler C, Bejjani BP, et al. Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease. J Cereb Blood Flow Metab 2009; 29: 235-43.
116. Percheron G, Francois C, Talbi B, Yelnik J, Febelon G. The primate motor thalamus. Brain Res Brain Res Rev 1996; 22: 93-181.
117. Pereira JB, Junqué C, Martí MJ, Ramirez-Ruiz B, Bartré s-Faz D, Tolosa E. Structural brain correlates of verbal fluency in Parkinson's disease. Neuroreport 2009; 20: 741-4.
118. Piao YS, Mori F, Hayashi S, Tanji K, Yoshimoto M, Kakita A, et al. Alpha-synuclein pathology affecting Bergmann glia of the cerebellum in patients with alpha-synucleinopathies. Acta Neuropathol 2003; 105: 403-9.
119. Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 1992; 32: 151-161.
120. Politis M, Wu K, Molloy S, Bain PG, Chaudhuri KR, Piccini P. Parkinson's disease symptoms: the patient's perspective. Mov Disord 2010; 25: 1646-51.
121. Pollock LJ, Davis L. Muscle tone in parkinsonian states. Arch Neurol Psychiatry 1930; 23: 303-19.
122. Pollok B, Makhloufi H, Butz M, Gross J, Timmermann L, Wojtecki L, et al. Levodopa affects functional brain networks in parkinsonian resting tremor. Mov Disord 2009; 24: 91-8.
123. Poston KL, Eidelberg D. Network biomarkers for the diagnosis and treatment of movement disorders. Neurobiol Dis 2009; 35: 141-7.
124. Purzner J, Paradiso GO, Cunic D, Saint-Cyr JA, Hoque T, Lozano AM, et al. Involvement of the basal ganglia and cerebellar motor pathways in the preparation of self-initiated and externally triggered movements in humans. J Neurosci 2007; 27: 6029-36.
125. Qureshy A, Kawashima R, Imran MB, Sugiura M, Goto R, Okada K, et al. Functional mapping of human brain in olfactory processing: a PET study. J Neurophysiol 2000; 84: 1656-66.
126. Rao SM, Harrington DL, Haaland KY, Bobholz JA, Cox RW, Binder Jr. Distributed neural systems underlying the timing of movements. J Neurosci 1997; 17: 5528-35.
127. Rascol O, Sabatini U, Fabre N, Brefel C, Loubinoux I, Celsis P, et al. The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients. Brain 1997; 120: 103-10.
128. Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with earlyParkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 2000; 342: 1484-91.
129. Rinne JO, Portin R, Ruottinen H, Nurmi E, Bergman J, Haaparanta M, Solin O. Cognitive impairment and the brain dopaminergic system in Parkinson's disease. [18F]fluorodopa positron emission tomographic study. Arch Neurol 2000; 57: 470-5.
130. Rivlin-Etzion M, Marmor O, Heimer G, Raz A, Nini A, Bergman H. Basal ganglia oscillations and pathophysiology of movement disorders. Curr Opin Neurobiol 2006; 16: 629-37.
131. Robledo P, Feger J. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulate and the pallidal complex: electrophysiological data. Brain Res 1990; 518: 47-54.
132. Rolland AS, Herrero MT, Garcia-Martinez V, Ruberg M, Hirsch EC, Franç ois C. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism. Brain 2007; 130: 265-75.
133. Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C, et al. Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 2000; 123: 394-403.
134. Sasaki K, Gemba H, Hashimoto S, Mizuno N. Influences of cerebellar hemispherectomy on slow potentials in the motor cortex preceding self paced hand movements in the monkey. Neurosci Lett 1979; 15: 23-8.
135. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990; 54: 823-827.
136. Schell GR, Strick PL. The origin of thalamic inputs to the arcuate premotor and supplementary motor areas. J Neurosci 1984; 4: 539-560.
137. Scherfler C, Schocke MF, Seppi K, Esterhammer R, Brenneis C, Jaschke W, et al. Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. Brain 2006; 129: 538-42.
138. Schrock LE, Ostrem JL, Turner RS, Shimamoto SA, Starr PA. The subthalamic nucleus in primary dystonia: Single-unit discharge characteristics. J Neurophysiol 2009; 102: 3740-52.
139. Schweder PM, Hansen PC, Green AL, Quaghebeur G, Stein J, Aziz TZ. Connectivity of the pedunculopontine nucleus in parkinsonian freezing of gait. Neuroreport 2010; 21: 914-6.
140. Sen S, Kawaguchi A, Truong Y, Lewis MM, Huang X. Dynamic changes in cerebello-thalamo-cortical motor circuitry during progression of Parkinson's disease. Neuroscience 2010; 166: 712-9.
141. Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001; 16: 507-10.
142. Small SL, Hlustik P, Noll DC, Genovese C, Solodkin A. Cerebellar hemispheric activation ipsilateral to the paretic hand correlates with functional recovery after stroke. Brain 2002; 125: 1544-57.
143. Smith Y, Bevan MD, Shink E, Bolam JP. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 1998; 86: 353-87.
144. Solano SM, Miller DW, Augood SJ, Young AB, Penney JB Jr. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Ann Neurol 2000; 47: 201-10.
145. Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007; 130: 1596-607.
146. Strick PL, Dum RP, Fiez JA. Cerebellum and nonmotor function. Annu Rev Neurosci 2009; 32: 413-34.
147. Takada M, Sugimoto T, Hattori T. MPTP neurotoxicity to cerebellar purkinje cells in mice. Neurosci Lett 1993; 150: 49-52.
148. Tan EK, Chandran VR, Fook-Chong S, Shen H, Yew K, Teoh ML, et al. Alpha-synuclein mRNA expression in sporadic Parkinson's disease. Mov Disord 2005; 20: 620-3.
149. Tang CC, Poston KL, Dhawan V, Eidelberg D. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci 2010; 30: 1049-56.
150. Tanji J, Hoshi E. Behavioral planning in the prefrontal cortex. Curr Opin Neurobiol 2001; 11: 164-1700
151. Timmermann L, Gross J, Butz M, Kircheis G, Haussinger D, Schnitzler A. Pathological oscillatory coupling within the human motor system in different tremor syndromes as revealed by magnetoencephalography. Neurol Clin Neurophysiol 2004; 2004: 26.
152. Timmermann L, Gross J, Dirks M, Volkmann J, Freund HJ, Schnitzler A. The cerebral oscillatory network of parkinsonian resting tremor. Brain 2003; 126: 199-212.
153. Turner RS, Grafton ST, McIntosh AR, DeLong MR, Hoffman JM. The functional anatomy of parkinsonian bradykinesia. Neuroimage 2003; 19: 163-179.
154. Vignola C, Nechi D, Scherini E, Bernocchi G. MPTP induced changes in the monkey cerebellum. Immunohistochemistry of calcium binding and cytoskeletal proteins. Neurodegeneration 1994; 3: 25-31.
155. Wagle-Shukla A, Angel MJ, Zadikoff C, Enjati M, Gunraj C, Lang AE, et al. Low-frequency repetitive transcranial magnetic stimulation for treatment of levodopa-induced dyskinesias. Neurology 2007; 68: 704-5.
156. Wang L, Yu C, Chen H, Qin W, He Y, Fan F, et al. Dynamic functional reorganization of the motor execution network after stroke. Brain 2010; 133: 1224-38.
157. Weiller C, Chollet F, Friston KJ, Wise RJ, Frackowiak RS. Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann Neurol 1992; 31: 463-72.
158. Werheid K, Zysset S, Müller A, Reuter M, von Cramon DY. Rule learning in a serial reaction time task: an fMRI study on patients with early Parkinson's disease. Brain Res Cogn Brain Res 2003; 16: 273-84.
159. Westerlund M, Belin AC, Anvret A, Ha° kansson A, Nissbrandt H, Lind C, et al. Cerebellar-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material. FASEB J 2008; 22: 3509-14.
160. Wu T, Chan P, Hallett M. Effective connectivity of neural networks in automatic movements in Parkinson's disease. NeuroImage 2010a; 49: 2581-7.
161. Wu T, Hallett M. A functional MRI study of automatic movements in patients with Parkinson's disease. Brain 2005; 128: 2250-59.
162. Wu T, Hallett M. Neural correlates of dual task performance in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2008; 79: 760-6.
163. Wu T, Long X, Zang Y, Wang L, Hallett M, Li K, Chan P. Regional homogeneity changes in patients with Parkinson's disease. Hum Brain Mapp 2009a; 30: 1502-10.
164. Wu T, Wang L, Chen Y, Zhao C, Li K, Chan P. Changes of functional connectivity of the motor network in the resting state in Parkinson's disease. Neurosci Lett 2009b; 460: 6-10.
165. Wu T, Wang L, Hallett M, Chen Y, Li K, Chan P. Effective connectivity of brain networks during self-initiated movement in Parkinson's disease. NeuroImage 2011; 55: 204-15.
166. Wu T, Wang L, Hallett M, Li K, Chan P. Neural correlates of bimanual anti-phase and in-phase movements in Parkinson's disease. Brain 2010b; 133: 2394-409.
167. Yang J, Sadler TR, Givrad TK, Maarek JM, Holschneider DP. Changes in brain functional activation during resting and locomotor states after unilateral nigrostriatal damage in rats. Neuroimage 2007; 36: 755-73.
168. Yu H, Sternad D, Corcos DM, Vaillancourt DE. Role of hyperactive cerebellum and motor cortex in Parkinson's disease. Neuroimage 2007; 35: 222-33.
169. Zaidel A, Arkadir D, Israel Z, Bergman H. Akineto-rigid vs. tremor syndromes in parkinsonism. Curr Opin Neurol 2009; 22: 387-93.
170. Zhang K, Yu C, Zhang Y, Wu X, Zhu C, Chan P, Li K. Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson's disease. Eur J Radiol 2011; 77: 269-73.